Open calls · Research grant · Biochemistry, Genetics and Molecular Biology
Cell and Gene Therapy for Personalised Medicine (CGT4PM2027)
EP PerMed · Horizon Europe cascade funding · European Partnership for Personalised Medicine · HORIZON-HLTH-2023-CARE-08-01
Deadlines
- 20 Jan 2027 Deadline in 70 days
Who can apply
- Countries
- EU member states and countries associated with Horizon Europe
Money
- Total budget
- €37M
About the call
With this JTC, EP PerMed will fund research projects in human health on Cell and Gene Therapies (CGT) for PM approaches. Proposals must focus on the development and validation of an innovative and novel CGT for PM.
At least one of the following approaches must be employed:
• Somatic cell therapeutics ;
• Gene therapeutics ;
• Combined cell- and gene therapeutics ;
• Novel biological products.
For the entire scope, please consult the Call Text: https://www.eppermed.eu/funding-projects/calls/jtc2027/ .
Text from the funder (European Commission, CC BY 4.0).
Conditions in full
All information and documents concerning the EP PerMed Joint Transnational Call (JTC) 2027, including the call text outlining the aims and scope of the call, the Guidelines for Applicants document, the pre-proposal form, etc. can be found here: https://www.eppermed.eu/funding-projects/calls/jtc2027/ .
Electronic submission system: https://ptoutline.eu/app/eppermed2027 .
Deadline to submit pre-proposals: 20 January 2027 (14:00, CET)
Deadline to submit full proposals: 25 May 2027 (14:00, CEST)
We sort calls into fields, career stages and countries automatically. Always check the conditions on the funder’s page before you apply.
Discussion
Applying too? Looking for partners? Ask here.